1. Screening and Brief Interventions for Illicit Drug Use and Alcohol Use in Methadone Maintained Opiate-Dependent Patients: Results of a Pilot Cluster Randomized Controlled Trial Feasibility Study.
- Author
-
Darker, Catherine D., Sweeney, Brion, Keenan, Eamon, Whiston, Lucy, Anderson, Rolande, and Barry, Joseph
- Subjects
- *
METHADONE treatment programs , *SUBSTANCE abuse prevention , *RESEARCH , *CHI-squared test , *CLUSTER analysis (Statistics) , *DRUG use testing , *MEDICAL cooperation , *PATIENT compliance , *PATIENT satisfaction , *PROBABILITY theory , *QUESTIONNAIRES , *REGRESSION analysis , *RESEARCH funding , *SELF-evaluation , *SUBSTANCE abuse , *T-test (Statistics) , *SUBSTANCE abuse treatment , *PILOT projects , *TREATMENT programs , *RANDOMIZED controlled trials , *MOTIVATIONAL interviewing , *DATA analysis software , *DESCRIPTIVE statistics - Abstract
Background and Objectives: The present study evaluated the effectiveness of a single clinician delivered brief intervention (BI) to reduce problem alcohol use and illicit substance use in an opiate-dependent methadone maintained cohort of patients attending for treatment. Methods: Four addiction treatment centers were randomly assigned to either treatment as usual (TAU; control group) or BI (intervention group). Clinicians screened patients using the alcohol, smoking, and substance involvement screening test (ASSIST) screening tool at baseline and again at three-month follow up. Fidelity checks were performed to ensure that training was delivered effectively and uniformly across all study sites. Feasibility of administering a BI within daily practice was assessed through intervention fidelity checks, patient satisfaction questionnaires and process evaluation. Results: A total of 465 patients were screened (66% of the overall eligible population) with a total of 433 (93%) ASSIST positive cases. Randomization was effective, with no differences in the control versus the intervention arms at baseline for key demographic or clinical indicators including substance us. There was a statistically significant difference between global risk score for the intervention (x = 39.36, sd = 25.91) group and the control group (x = 45.27, SD = 27.52) at 3-month follow-up (t(341) = −2.07, p <.05). Conclusions: This trial provides the first evidence that a single clinician delivered BI can result in a reduction in substance use within a methadone maintained opiate-dependent cohort, and this effect is sustained at three month follow up. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF